.
MAB Discovery is headquartered in Munich, Germany.
MAB Discovery is a life science company.
MAB Discovery was founded in 2010.
Join Mergr to view all 0 acquisitions of life science companies in , including .
Forstenrieder Straße 8 - 14,
Munich,
82061
Germany,
+49 89 990 178-0
www.mabdiscovery.com
MAB Discovery GmbH utilizes a unique and proprietary rabbit-based antibody discovery platform to generate and develop high quality, functional monoclonal antibodies targeting traditional proteins and receptors as well as a wide variety of more challenging immunogens such as GPCRs and ion channels. The MAB Discovery team has extensive experience in developing antibody-based therapeutics having worked together at Roche Biologicals for several years. In recent years, MABD used its proprietary platform to generate various mAbs for several pharma partners and for the generation of proprietary mAbs focusing on highly attractive targets with proven therapeutic relevance.
| Year | ≤ '19 | '20 | '21 | '22 | '23 | '24 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | - | - | - | - | - | - | 0 |
| Sell (0.0/yr) | # | 1 | - | - | - | - | - | 1 |
| 1 | ||||||||
| Company | Date | Value | Type |
|---|---|---|---|
| MAB Discovery GmbH - Antibody Generation Unit Business | 2019-01-23 | - | Divestiture |
| Munich, Germany | |||
| View All >> | |||
| Sector | Buy # | Value | Sell # | Value | |
|---|---|---|---|---|---|
| Life Science | - | - | 1 (100%) | - | |
| Total | - | - | 1 | - | |
| State/Country | Buy | Value | Sell | Value | ||
|---|---|---|---|---|---|---|
| Germany | - | - | 1 | - | ||
| Total | - | - | 1 | - | ||
| Deals | ||
|---|---|---|
| Divested to | ||
| Strategic(s) |
|
1 (100%) |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.
Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.
Try us for 1 week free today!
No obligation. Cancel anytime.
